Skip to content
10-Q

Quarterly Report

ACCENDRA HEALTH INC/VA/ ACH

0001558370-25-011059

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 77.24M sh
Shares Diluted Q2 2025 · Jun 30, 2025 76.94M sh
Shares Diluted Q2 2025 · Jun 30, 2025 77.1M sh
Shares Diluted Q2 2025 · Jun 30, 2024 76.73M sh
Shares Diluted Q2 2025 · Jun 30, 2024 76.53M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $6.66M
Stock Repurchased Q2 2025 · Jun 30, 2024 $0
Capex Q2 2025 · Jun 30, 2025 $123.58M
Capex Q2 2025 · Jun 30, 2024 $90.38M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $2.54M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $63.19M
Short Term Debt Q2 2025 · Jun 30, 2025 $383M
Short Term Debt Q2 2025 · Dec 31, 2024 $42.87M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $38.26M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $27.57M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$281.01M
Stockholders Equity Q2 2025 · Mar 31, 2025 $570.98M
Stockholders Equity Q2 2025 · Dec 31, 2024 $586.36M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $881.84M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 $916.01M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 $945.3M
Current Liabilities Q2 2025 · Jun 30, 2025 $2.67B
Current Liabilities Q2 2025 · Dec 31, 2024 $1.85B
Total Liabilities Q2 2025 · Jun 30, 2025 $4.44B
Total Liabilities Q2 2025 · Dec 31, 2024 $4.07B
Current Assets Q2 2025 · Jun 30, 2025 $2.3B
Current Assets Q2 2025 · Dec 31, 2024 $2.02B
Total Assets Q2 2025 · Jun 30, 2025 $4.15B
Total Assets Q2 2025 · Dec 31, 2024 $4.66B
Eps Diluted Q2 2025 · Jun 30, 2025 −$11.30
Eps Diluted Q2 2025 · Jun 30, 2025 −$11.60
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.42
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.70
Eps Basic Q2 2025 · Jun 30, 2025 −$11.30
Eps Basic Q2 2025 · Jun 30, 2025 −$11.60
Eps Basic Q2 2025 · Jun 30, 2024 −$0.42
Eps Basic Q2 2025 · Jun 30, 2024 −$0.70
Sga Expense Q2 2025 · Jun 30, 2025 $267.85M
Sga Expense Q2 2025 · Jun 30, 2025 $530.22M
Sga Expense restated Q2 2025 · Jun 30, 2024 $269.92M
Sga Expense restated Q2 2025 · Jun 30, 2024 $540.13M
Net Income Q2 2025 · Jun 30, 2025 −$869.06M
Net Income Q2 2025 · Jun 30, 2025 −$894.04M
Net Income Q2 2025 · Mar 31, 2025 −$24.98M
Net Income Q2 2025 · Jun 30, 2024 −$31.91M
Net Income Q2 2025 · Jun 30, 2024 −$53.8M
Net Income Q2 2025 · Mar 31, 2024 −$21.89M
Operating Income Q2 2025 · Jun 30, 2025 −$39.71M
Operating Income Q2 2025 · Jun 30, 2025 −$19.92M
Operating Income restated Q2 2025 · Jun 30, 2024 $16.92M
Operating Income restated Q2 2025 · Jun 30, 2024 $23.89M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $357.32M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $711.96M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $344.37M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $682.62M
Revenue Q2 2025 · Jun 30, 2025 $681.92M
Revenue Q2 2025 · Jun 30, 2025 $1.36B
Revenue restated Q2 2025 · Jun 30, 2024 $660.4M
Revenue restated Q2 2025 · Jun 30, 2024 $1.3B